Today: September 12, 2024
Today: September 12, 2024

Pharmaceuticals

Health|Science

Pharma aims to deliver personalized cancer therapies more quickly

Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming

Pharma aims to deliver personalized cancer therapies more quickly
Business|Europe|Health

Germany's Merck raises 2024 forecast on healthcare, electronics units' performance

Germany's Merck on Friday raised its forecast for the group, mainly driven by a strong operating performance at its healthcare and electronics units.

Germany's Merck raises 2024 forecast on healthcare, electronics units' performance
Business|Finance|Health

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
Business|Economy|Health

AstraZeneca raises profit outlook on strong medicines demand

Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday after beating analyst expectations for second-quarter

AstraZeneca raises profit outlook on strong medicines demand
Business|Economy|Health

Swiss pharma firm Lonza's profit falls less than feared, shares rise

Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a strong performance in its core

Swiss pharma firm Lonza's profit falls less than feared, shares rise
Business|Economy|Finance|Health

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products

Sanofi on Thursday raised its full-year profit outlook after strong demand for blockbuster asthma drug Dupixent and better-than-expected sales of new launches helped its

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Business|Finance|Health

Roche lifts 2024 profit guidance on strong drug sales

Roche on Thursday raised its full-year earnings forecast after exceeding expectations for the first half, driven by strong demand for newer drugs such as eye

Roche lifts 2024 profit guidance on strong drug sales
Europe|Health

EU regulator backs use of Novo's Wegovy to lower heart risks

The European Medicines Agency has backed the use of Novo Nordisk's Wegovy to lower major heart risks and strokes in overweight or obese adults without diabetes, the Danish drugmaker said on

EU regulator backs use of Novo's Wegovy to lower heart risks
Business|Economy|Finance

India's Mankind Pharma to buy Bharat Serums in a $1.6 billion deal

Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.

India's Mankind Pharma to buy Bharat Serums in a $1.6 billion deal
Business|Economy|Health

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high

Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Friday as it reported higher sales in its North

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high
Business|Health|News

Tornado-damaged Pfizer plant in North Carolina restarts production

A major Pfizer pharmaceutical plant has restarted production, 10 weeks after it was heavily damaged by a tornado

Tornado-damaged Pfizer plant in North Carolina restarts production
Business|Health|News|World

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Business

Eli Lilly settles whistleblower lawsuit over manufacturing problems

Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing

Eli Lilly settles whistleblower lawsuit over manufacturing problems
Business

Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline

Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging him to take "immediate action" to expand access to the company's tuberculosis

Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline
Business

US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic

A U.S.

US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
News

Drugmakers sign on to negotiate Medicare prices under protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S.

Drugmakers sign on to negotiate Medicare prices under protest
Business

Eli Lilly to buy Point Biopharma for $1.4 billion

Eli Lilly and Co has agreed to acquire Point Biopharma Global in an all-cash deal valued at $1.4 billion, the two companies said on Tuesday.

Eli Lilly to buy Point Biopharma for $1.4 billion
Business

Eli Lilly's head of diabetes and obesity unit to retire

Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire by the end of the year after more than three decades with the drugmaker.

Eli Lilly's head of diabetes and obesity unit to retire
Business

Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News

Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter.

Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
News

New COVID shots still hard to find for some Americans

Americans have started rolling up their sleeves for the latest version of the COVID-19 vaccine, but weeks into the rollout some

New COVID shots still hard to find for some Americans
Business|Health|News

California Gov. Gavin Newsom vetoes bill aimed at limiting the price of insulin

California Gov. Gavin Newsom has vetoed a bill aimed at limiting the price of insulin

California Gov. Gavin Newsom vetoes bill aimed at limiting the price of insulin
Business

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion deal

Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics for $58 per share in cash, representing $4.8 billion equity value.

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Business

Weight-loss drugs fuel boom for firms that fill syringes

Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the

Weight-loss drugs fuel boom for firms that fill syringes
Business

Ozempic's early success in kidney disease trial drags down dialysis stocks

Shares of dialysis service providers fell sharply on Wednesday after Novo Nordisk's Ozempic showed early signs of success in delaying the progression of kidney disease in

Ozempic's early success in kidney disease trial drags down dialysis stocks
Business

Pfizer lowers full-year revenue forecast, shares fall

Pfizer Inc on Friday cut forecast for 2023 revenue to between $58 billion and $61 billion, from $67 billion to $70 billion previously.

Pfizer lowers full-year revenue forecast, shares fall

Follow